Concepedia

Dong‐Wan Kim

DK

261

Publications

31.4K

Citations

71

H-Index

1999

Active since

Affiliations

Seoul National University Hospital(Current)

Seoul National University

Samsung Medical Center

Sungkyunkwan University

Asan Medical Center

Dong‐Wan Kim is an author at Seoul National University Hospital specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

1999–2025

261

Publications

261

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S. Herbst, Paul Baas, Dong‐Wan Kim et al. · The Lancet · 2015 · 6.4K citations

, , +7

Alectinib versus Crizotinib in Untreated <i>ALK</i>-Positive Non–Small-Cell Lung Cancer

Solange Peters, D. Ross Camidge, Alice T. Shaw et al. · New England Journal of Medicine · 2017 · 2.4K citations · Full text

Virus-Enabled Synthesis and Assembly of Nanowires for Lithium Ion Battery Electrodes

Ki Tae Nam, Dong‐Wan Kim, Pil J. Yoo et al. · Science · 2006 · 1.8K citations

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

D. Ross Camidge, Yung‐Jue Bang, Eunice L. Kwak et al. · The Lancet Oncology · 2012 · 1.3K citations · Full text

, , +10

First-Line Lorlatinib or Crizotinib in Advanced <i>ALK</i> -Positive Lung Cancer

Alice T. Shaw, Todd M. Bauer, Filippo de Marinis et al. · New England Journal of Medicine · 2020 · 1K citations · Full text

Rows per page

1–5 of 261